Literature DB >> 28645576

Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones.

Dino Luethi1, Matthias E Liechti1, Stephan Krähenbühl2.   

Abstract

Synthetic cathinones are a new class of psychostimulant substances. Rarely, they can cause liver injury but associated mechanisms are not completely elucidated. In order to increase our knowledge about mechanisms of hepatotoxicity, we investigated the effect of five frequently used cathinones on two human cell lines. Bupropion was included as structurally related drug used therapeutically. In HepG2 cells, bupropion, MDPV, mephedrone and naphyrone depleted the cellular ATP content at lower concentrations (0.2-1mM) than cytotoxicity occurred (0.5-2mM), suggesting mitochondrial toxicity. In comparison, methedrone and methylone depleted the cellular ATP pool and induced cytotoxicity at similar concentrations (≥2mM). In HepaRG cells, cytotoxicity and ATP depletion could also be demonstrated, but cytochrome P450 induction did not increase the toxicity of the compounds investigated. The mitochondrial membrane potential was decreased in HepG2 cells by bupropion, MDPV and naphyrone, confirming mitochondrial toxicity. Bupropion, but not the other compounds, uncoupled oxidative phosphorylation. Bupropion, MDPV, mephedrone and naphyrone inhibited complex I and II of the electron transport chain, naphyrone also complex III. All four mitochondrial toxicants were associated with increased mitochondrial ROS and increased lactate production, which was accompanied by a decrease in the cellular total GSH pool for naphyrone and MDPV. In conclusion, bupropion, MDPV, mephedrone and naphyrone are mitochondrial toxicants impairing the function of the electron transport chain and depleting cellular ATP stores. Since liver injury is rare in users of these drugs, affected persons must have susceptibility factors rendering them more sensitive for these drugs.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cathinones; Electron transport chain; Liver injury; Mitochondria; New psychoactive substances; ROS

Mesh:

Substances:

Year:  2017        PMID: 28645576     DOI: 10.1016/j.tox.2017.06.004

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  16 in total

1.  Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Kaveish Sewalia; Lucas R Watterson; Alyssa Hryciw; Anna Belloc; J Bryce Ortiz; M Foster Olive
Journal:  Neuropharmacology       Date:  2017-11-26       Impact factor: 5.250

Review 2.  How preclinical studies have influenced novel psychoactive substance legislation in the UK and Europe.

Authors:  Raquel Santos-Toscano; Amira Guirguis; Colin Davidson
Journal:  Br J Clin Pharmacol       Date:  2020-02-23       Impact factor: 4.335

3.  Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports.

Authors:  Michal Ordak; Aleksandra Zmysłowska; Miłosz Bielski; Daniel Rybak; Maja Tomaszewska; Katarzyna Wyszomierska; Aleksandra Kmiec; Natalia Garlicka; Maria Zalewska; Michal Zalewski; Tadeusz Nasierowski; Elzbieta Muszynska; Magdalena Bujalska-Zadrozny
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

4.  From street to lab: in vitro hepatotoxicity of buphedrone, butylone and 3,4-DMMC.

Authors:  Rita Roque Bravo; Helena Carmo; Maria João Valente; João Pedro Silva; Félix Carvalho; Maria de Lourdes Bastos; Diana Dias da Silva
Journal:  Arch Toxicol       Date:  2021-02-07       Impact factor: 5.153

5.  Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine.

Authors:  Dawn E Muskiewicz; Federico Resendiz-Gutierrez; Omar Issa; F Scott Hall
Journal:  Pharmacol Biochem Behav       Date:  2020-02-12       Impact factor: 3.533

6.  In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Ana Margarida Araújo; Márcia Carvalho; Vera Marisa Costa; José Alberto Duarte; Ricardo Jorge Dinis-Oliveira; Maria de Lourdes Bastos; Paula Guedes de Pinho; Félix Carvalho
Journal:  Arch Toxicol       Date:  2020-11-19       Impact factor: 5.153

Review 7.  Psychiatric drugs impact mitochondrial function in brain and other tissues.

Authors:  Shawna T Chan; Michael J McCarthy; Marquis P Vawter
Journal:  Schizophr Res       Date:  2019-11-16       Impact factor: 4.939

8.  Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells.

Authors:  Teresa Coccini; Sarah Vecchio; Marta Crevani; Uliana De Simone
Journal:  Neurotox Res       Date:  2018-06-22       Impact factor: 3.911

Review 9.  Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?

Authors:  Jonna M Leyrer-Jackson; Erin K Nagy; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2018-10-27       Impact factor: 4.530

Review 10.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.